Medical Researcher: The experimental drug Lexicon has demonstrated a remarkable ability to neutralize the synthetic pathogen V-7 in laboratory settings. Based on this, several public health officials are lobbying for its immediate mass production. This enthusiasm is unwarranted. Historical data reveals that of all the experimental drugs that successfully neutralized synthetic pathogens in laboratories over the past twenty years, fewer than ten percent were ultimately approved as safe for public consumption. Consequently, there is a greater than ninety percent probability that Lexicon will fail to neutralize V-7 in human patients.
The reasoning in the medical researcher's argument is most vulnerable to criticism on the grounds that the argument does which one of the following?
- Afails to distinguish between a condition that is necessary for a drug to be approved for public consumption and a condition that is sufficient for such approval
- overlooks the possibility that a drug can successfully neutralize a pathogen in human patients even if it is not ultimately approved as safe for public consumptionAnswer
- Cattempts to undermine the public health officials' position by criticizing their enthusiasm rather than addressing the scientific merit of their lobbying efforts
- Dtakes for granted that a correlation between a drug's success in laboratory settings and its failure in human safety trials indicates a causal relationship
- Epresumes, without providing justification, that the historical failure rate of a broad category of experimental drugs accurately determines the probability of success for one specific drug within that category